"Bear is there anything else that Clayton added or expanded on in your conversation? Did he give an idea (or subtle indication) when we may hear about an FDA inclusion or exclusion in the BM trial.?"

It was a very nice conversation with Clayton. I did also ask Clayton about the status of enrollment and also specifically about Taiwan and Russia. He said that the last number that they announced was just over 1400 patients; however, I forgot to ask when that number was from. So I'm not sure if 1400 was as of June, May, or April. I do recall that in mid-March they announced that they were just over 1200. As for Taiwan, Clayton told me that there are 2 sites in Taiwan that are open and recruiting. As for Russia, it sounds like everything is all lined up and they should open their study sites for recruitment imminently. They are still hopeful and optimistic that the FDA will allow inclusion of US sites in current BETonMACE, but are preparing a contigency plan of the future US BETonMACE just in case. I got the impression that Resverlogix has done all they can and are patiently waiting for resolution from FDA. 

BDAZ